Effect of glucuronidation on transport and tissue accumulation of tyrosine kinase inhibitors: consequences for the clinical management of sorafenib and regorafenib-Reference-Cited by-同舟云学术

Effect of glucuronidation on transport and tissue accumulation of tyrosine kinase inhibitors: consequences for the clinical management of sorafenib and regorafenib

Published:2015-03-25 Issue:5 Volume:11 Page:785-794
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Tlemsani Camille,Huillard Olivier,Arrondeau Jennifer,Boudou-Rouquette Pascaline,Cessot Anatole,Blanchet Benoit,Thomas-Schoemann Audrey,Coriat Romain,Durand Jean-Philippe,Giroux Julie,Alexandre Jérôme,Goldwasser François

Publisher

Informa Healthcare

Subject

Pharmacology,Toxicology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/17425255.2015.1030392

Reference57 articles.

1. Antiangiogenic therapy: impact on invasion, disease progression, and metastasis

2. Sorafenib in Advanced Hepatocellular Carcinoma

3. Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma

4. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

5. The UDP-glucuronosyltransferases: Their role in drug metabolism and detoxification

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of a botanical compound as a broad-spectrum inhibitor against gut microbial β-glucuronidases from the Tibetan medicine Rhodiola crenulata;International Journal of Biological Macromolecules;2024-05

2. A Potent Solution for Tumor Growth and Angiogenesis Suppression via an ELR⁺CXCL-CXCR1/2 Pathway Inhibitor;ACS Medicinal Chemistry Letters;2024-04-03

3. p38 mitogen-activated protein kinase inhibitors;Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy;2024

4. Pharmacology of Tyrosine Kinase Inhibitors;Clinical Journal of the American Society of Nephrology;2023-12-11

5. Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance;Pharmacology & Therapeutics;2023-08